Artigos de revistas sobre o tema "Factor VIII (FVIII)"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Factor VIII (FVIII)".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Yada, Koji, Kenichi Ogiwara, Masaru Shibata, Midori Shima e Keiji Nogami. "Effects of anti-factor VIII inhibitor antibodies on factor VIIa/tissue factor-catalysed activation and inactivation of factor VIII". Thrombosis and Haemostasis 105, n.º 06 (2011): 989–98. http://dx.doi.org/10.1160/th10-12-0781.
Texto completo da fonteYada, Koji, Keiji Nogami, Kenichi Ogiwara, Katsumi Nishiya, Masahiro Takeyama e Midori Shim. "Effects of Anti-FVIII Inhibitors On Factor VIIa/Tissue Factor-Catalyzed Activation and Inactivation of Factor VIII." Blood 114, n.º 22 (20 de novembro de 2009): 3169. http://dx.doi.org/10.1182/blood.v114.22.3169.3169.
Texto completo da fonteNakajima, Yuto, Koji Yada, Keiji Nogami e Midori Shima. "A Novel Mechanism of Factor VIIa/Tissue Factor (TF)-Catalyzed Activation and Inactivation of B-Domain-Deleted Factor VIII in the Early Initiation Phases of Coagulation". Blood 132, Supplement 1 (29 de novembro de 2018): 1162. http://dx.doi.org/10.1182/blood-2018-99-115645.
Texto completo da fonteOgiwara, Kenichi, Keiji Nogami, Masahiro Okuda, Katsumi Nishiya, Masahiro Takeyama e Midori Shima. "Interactions of Factor VIII with Tissue Factor Contributes to the Acceleration of Factor Xa Generation in the Initiation Phase of Blood Coagulation." Blood 114, n.º 22 (20 de novembro de 2009): 3177. http://dx.doi.org/10.1182/blood.v114.22.3177.3177.
Texto completo da fonteOgiwara, Kenichi, Keiji Nogami, Tetsuhiro Soeda, Tomoko Matsumoto, Katsumi Nishiya e Midori Shima. "Mechanisms of Factor VIII Activation by Recombinant Factor VIIa Analog through Tissue Factor-Independent Manner". Blood 112, n.º 11 (16 de novembro de 2008): 1028. http://dx.doi.org/10.1182/blood.v112.11.1028.1028.
Texto completo da fonteMeeks, Shannon, Ernest T. Parker, Amy L. Dunn, John F. Healey e Pete Lollar. "Proteolytically Inactivatable Factor VIII is Less Immunogenic than Factor VIII in a Murine Hemophilia A Model." Blood 114, n.º 22 (20 de novembro de 2009): 27. http://dx.doi.org/10.1182/blood.v114.22.27.27.
Texto completo da fonteSoeda, Tetsuhiro, Keiji Nogami, Tomoko Matsumoto, Kenichi Ogiwara, Katsumi Nishiya e Midori Shima. "Tissue Factor-Dependent Activation of Factor VIII by Factor VIIa in the Early Phase of Blood Coagulation". Blood 112, n.º 11 (16 de novembro de 2008): 1036. http://dx.doi.org/10.1182/blood.v112.11.1036.1036.
Texto completo da fonteMesser, Amanda S., Barbara Ulmasov, Yogesh Kumar, Kanagasabai Vadivel, Degang Zhong, Philip Fay e S. Paul Bajaj. "Epitope Mapping of a Monoclonal Antibody to Factor VIII That Inhibits Factor IXa:Factor VIIIa Interaction and Thrombin Activation of Factor VIII". Blood 118, n.º 21 (18 de novembro de 2011): 1177. http://dx.doi.org/10.1182/blood.v118.21.1177.1177.
Texto completo da fonteZakas, Philip, Kristopher Knight, Ernest T. Parker, H. Trent Spencer, Eric Gaucher e Christopher B. Doering. "Bioengineering Coagulation Factor VIII through Ancestral Protein Reconstruction". Blood 126, n.º 23 (3 de dezembro de 2015): 123. http://dx.doi.org/10.1182/blood.v126.23.123.123.
Texto completo da fonteRadtke, Klaus-Peter, Dean Chamberlain, John H. Griffin e Andrew J. Gale. "Whole Blood Thromboelastogram Assays Demonstrate Prolonged Factor VIIIa Potency for Recombinant Disulfide Bond-Stabilized Factor VIII Variants." Blood 104, n.º 11 (16 de novembro de 2004): 2976. http://dx.doi.org/10.1182/blood.v104.11.2976.2976.
Texto completo da fonteOgiwara, Kenichi, Midori Shima e Keiji Nogami. "Factor VIII activation by factor VIIa analog (V158D/E296V/M298Q) in tissue factor-independent mechanisms". Thrombosis and Haemostasis 106, n.º 10 (2011): 665–74. http://dx.doi.org/10.1160/th11-04-0264.
Texto completo da fonteTakeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori e Midori Shima. "Characterisation of an antibody specific for coagulation factor VIII that enhances factor VIII activity". Thrombosis and Haemostasis 103, n.º 01 (2010): 94–102. http://dx.doi.org/10.1160/th09-05-0338.
Texto completo da fonteShoko, Furukawa, Keiji Nogami, Kenichi Ogiwara e Midori Shima. "Mechanism of Tissue Factor (TF) Enhancing Factor (F)VIII Activity on FXa Generation in Initial Phase of Coagulation and Interaction Between TF and FVIII C2 Domain". Blood 128, n.º 22 (2 de dezembro de 2016): 1391. http://dx.doi.org/10.1182/blood.v128.22.1391.1391.
Texto completo da fonteWilhelm, Amelia R., Nicole A. Parsons, Benjamin J. Samelson-Jones, Robert J. Davidson, Charles T. Esmon, Rodney M. Camire e Lindsey A. George. "Activated protein C has a regulatory role in factor VIII function". Blood 137, n.º 18 (6 de maio de 2021): 2532–43. http://dx.doi.org/10.1182/blood.2020007562.
Texto completo da fonteRozenshteyn, Diana, e Andrew J. Gale. "Cathepsin G, a leukocyte protease, activates coagulation factor VIII". Thrombosis and Haemostasis 99, n.º 01 (2008): 44–51. http://dx.doi.org/10.1160/th07-08-0495.
Texto completo da fonteHausl, Christina, Rafi U. Ahmad, Maria Sasgary, Christopher B. Doering, Pete Lollar, Günter Richter, Hans Peter Schwarz, Peter L. Turecek e Birgit M. Reipert. "High-dose factor VIII inhibits factor VIII–specific memory B cells in hemophilia A with factor VIII inhibitors". Blood 106, n.º 10 (15 de novembro de 2005): 3415–22. http://dx.doi.org/10.1182/blood-2005-03-1182.
Texto completo da fonteDoshi, Bhavya, Courtney Cox, Bagirath Gangadharan, Christopher B. Doering e Shannon L. Meeks. "Factor VIII Supplementation Improves Recombinant VIIa Initiated Thrombin Generation in Hemophilia A Inhibitor Patient Plasmas". Blood 118, n.º 21 (18 de novembro de 2011): 28. http://dx.doi.org/10.1182/blood.v118.21.28.28.
Texto completo da fonteZhong, Degang, Evgueni L. Saenko, Midori Shima, Matthew Felch e Dorothea Scandella. "Some Human Inhibitor Antibodies Interfere With Factor VIII Binding to Factor IX". Blood 92, n.º 1 (1 de julho de 1998): 136–42. http://dx.doi.org/10.1182/blood.v92.1.136.413k35_136_142.
Texto completo da fontePonder, Katherine P. "FIXing Factor VIII inhibitors". Blood 119, n.º 2 (12 de janeiro de 2012): 325–26. http://dx.doi.org/10.1182/blood-2011-11-389486.
Texto completo da fontePeerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A". Blood 93, n.º 7 (1 de abril de 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.
Texto completo da fontePeerlinck, Kathelijne, Marc G. Jacquemin, Jef Arnout, Marc F. Hoylaerts, Jean Guy G. Gilles, Renaud Lavend’homme, Karen M. Johnson et al. "Antifactor VIII Antibody Inhibiting Allogeneic but not Autologous Factor VIII in Patients With Mild Hemophilia A". Blood 93, n.º 7 (1 de abril de 1999): 2267–73. http://dx.doi.org/10.1182/blood.v93.7.2267.407k21_2267_2273.
Texto completo da fonteTakeyama, Masahiro, Keiji Nogami, Tetsuhiro Soeda, Tsukasa Suzuki, Kunihiro Hattori, Kohei Tatsumi, Yuri Fujita, Ichiro Tanaka, Akira Yoshioka e Midori Shima. "Characterization of an Anti-Factor VIII Monoclonal Antibody with A1 and A3 Epitopes Which Increases Factor VIII Activity." Blood 108, n.º 11 (16 de novembro de 2006): 1702. http://dx.doi.org/10.1182/blood.v108.11.1702.1702.
Texto completo da fonteGale, Andrew J., Diana Rozenshteyn e Justin Riceberg. "The Neutrophil Proteases, Elastase and Cathepsin G, May Modulate the Activity of Factor VIII." Blood 108, n.º 11 (16 de novembro de 2006): 1716. http://dx.doi.org/10.1182/blood.v108.11.1716.1716.
Texto completo da fonteNogami, Keiji, Katsumi Nishiya, Yoshihiko Sakurai, Ichiro Tanaka, John Giddings, Evgueni Saenko, Akira Yoshioka e Midori Shima. "Human Factor VIII Inhibitor Alloantibodies with a C2 Epitope Inhibit Factor Xa-catalyzed Factor VIII Activation: A new Anti-factor VIII Inhibitory Mechanism". Thrombosis and Haemostasis 87, n.º 03 (2002): 459–65. http://dx.doi.org/10.1055/s-0037-1613026.
Texto completo da fonteOkayama, Yusuke, Masato Bingo, Kazuki Sakatoku, Hiroshi Okamura, Satoru Nanno, Mitsutaka Nishimoto, Yasuhiro Nakashima, Hideo Koh, Masayuki Hino e Hirohisa Nakamae. "The safety of the combination therapy of recombinant factor VIIa and plasma-derived factor VIIa and factor X for refractory hemorrhage in acquired hemophilia A". Blood Coagulation & Fibrinolysis 34, n.º 6 (19 de julho de 2023): 419–22. http://dx.doi.org/10.1097/mbc.0000000000001243.
Texto completo da fonteTakeyama, Masahiro, Keiji Nogami, Tomoko Matsumoto e Midori Shima. "Factor VIII A2 Domain Contains a Binding Site for Factor X". Blood 124, n.º 21 (6 de dezembro de 2014): 4226. http://dx.doi.org/10.1182/blood.v124.21.4226.4226.
Texto completo da fonteNeuenschwander, Pierre F. "Evidence of Abnormal Coagulation: Production of Factor VIII α-Fragment In Vivo." Blood 106, n.º 11 (16 de novembro de 2005): 1020. http://dx.doi.org/10.1182/blood.v106.11.1020.1020.
Texto completo da fonteYork, Elizabeth S., Jasmine Ito e Glaivy Batsuli. "Investigating persistent factor VIII-specific IgM in the humoral immune response to factor VIII". Journal of Immunology 210, n.º 1_Supplement (1 de maio de 2023): 229.12. http://dx.doi.org/10.4049/jimmunol.210.supp.229.12.
Texto completo da fonteYada, Koji, Keiji Nogami, Kenichi Ogiwara e Midori Shima. "A novel mechanism of Enhancing the Haemostatic Effect in the Combination with Recombinant Factor VIII and Activated Prothrombin Complex Concentrate(APCC) in Hemophilia A Patients with Inhibitor". Blood 118, n.º 21 (18 de novembro de 2011): 1178. http://dx.doi.org/10.1182/blood.v118.21.1178.1178.
Texto completo da fonteHsu, Ting-Chang, Kathleen P. Pratt e Arthur R. Thompson. "The factor VIII C1 domain contributes to platelet binding". Blood 111, n.º 1 (1 de janeiro de 2008): 200–208. http://dx.doi.org/10.1182/blood-2007-01-068957.
Texto completo da fonteGrushin, Kirill, Jaimy Miller, Daniela Dalm e Svetla Stoilova-McPhie. "Factor VIII organisation on nanodiscs with different lipid composition". Thrombosis and Haemostasis 113, n.º 04 (julho de 2015): 741–49. http://dx.doi.org/10.1160/th14-09-0725.
Texto completo da fonteRussell, Joshua, Yesim Dargaud, Randal J. Kaufman, Claude Negrier e Steven W. Pipe. "Inactivation-Resistant Recombinant Factor VIII Exhibits Superior Thrombin Generation Capacity in Comparison to Wild-Type and B Domain-Deleted Factor VIII." Blood 108, n.º 11 (16 de novembro de 2006): 1604. http://dx.doi.org/10.1182/blood.v108.11.1604.1604.
Texto completo da fonteFoster, PA, CA Fulcher, RA Houghten e TS Zimmerman. "Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine". Blood 75, n.º 10 (15 de maio de 1990): 1999–2004. http://dx.doi.org/10.1182/blood.v75.10.1999.bloodjournal75101999.
Texto completo da fonteHealey, John F., Ernest Parker e John (Pete) S. Lollar. "Comparative Decay Rates of Human, Rhesus Macaque, Cynomolgus, and Porcine Activated Factor VIII." Blood 114, n.º 22 (20 de novembro de 2009): 3164. http://dx.doi.org/10.1182/blood.v114.22.3164.3164.
Texto completo da fonteNovakovic, Valerie A., David B. Cullinan, Hironao Wakabayashi, Philip J. Fay, James D. Baleja e Gary E. Gilbert. "Membrane-binding properties of the Factor VIII C2 domain". Biochemical Journal 435, n.º 1 (15 de março de 2011): 187–96. http://dx.doi.org/10.1042/bj20101797.
Texto completo da fonteFoster, PA, CA Fulcher, RA Houghten e TS Zimmerman. "Synthetic factor VIII peptides with amino acid sequences contained within the C2 domain of factor VIII inhibit factor VIII binding to phosphatidylserine". Blood 75, n.º 10 (15 de maio de 1990): 1999–2004. http://dx.doi.org/10.1182/blood.v75.10.1999.1999.
Texto completo da fonteLivnat, Tami, Amy L. Dunn, Shirley Azar-Avivi, Wallace Hunter Baldwin, Gili Kenet e Shannon L. Meeks. "Epitope Specific Discrepancies Between Antibody Mediated Inhibition Of Recombinant Factor VIII and Plasma Derived Factor VIII Containing Von Willebrand Factor Affecting All Domains Of Factor VIII". Blood 122, n.º 21 (15 de novembro de 2013): 1089. http://dx.doi.org/10.1182/blood.v122.21.1089.1089.
Texto completo da fonteLannert, Kerry W., Hilary S. Gammill, Barbara A. Konkle e Jill M. Johnsen. "The Ability of Von Willebrand Factor (VWF) to Bind Factor VIII (FVIII) Can Decrease during Pregnancy". Blood 124, n.º 21 (6 de dezembro de 2014): 4244. http://dx.doi.org/10.1182/blood.v124.21.4244.4244.
Texto completo da fonteGangadharan, Bagirath, H. Trent Spencer, Ernest T. Parker e Christopher B. Doering. "High-Level Expression of Porcine Factor VIII from Murine Mesenchymal Stem Cells." Blood 104, n.º 11 (16 de novembro de 2004): 5281. http://dx.doi.org/10.1182/blood.v104.11.5281.5281.
Texto completo da fonteMinami, Hiroaki, Keiji Nogami, Takehisa Kitazawa, Kunihiro Hattori e Midori Shima. "FVIII Heavy Chain Enhances Tenase Activity Induced By FVIIIa Mimicking Bispesific Antibody, ACE910". Blood 124, n.º 21 (6 de dezembro de 2014): 1481. http://dx.doi.org/10.1182/blood.v124.21.1481.1481.
Texto completo da fonteNovakovic, Valerie A., James D. Baleja e Gary E. Gilbert. "The Factor VIIII C2 Domain Shows Stereospecificity for Phosphatidyl-L-Serine and Increases Factor IXa Activity". Blood 112, n.º 11 (16 de novembro de 2008): 3090. http://dx.doi.org/10.1182/blood.v112.11.3090.3090.
Texto completo da fonteRolli, Veronique, Nathalie Enjolras, Cecile Ducasse, Marie-Helene Rodriguez, Thomas Weimer, Hans-Peter Hauser, Claude Negrier e Jean-Luc Plantier. "Generation of Factor VIII Molecules Partially Resistant to Activated Protein C." Blood 104, n.º 11 (16 de novembro de 2004): 1729. http://dx.doi.org/10.1182/blood.v104.11.1729.1729.
Texto completo da fonteMarkovitz, Rebecca C., John F. Healey, W. Hunter Baldwin, Ernest T. Parker, Shannon L. Meeks e Pete Lollar. "Decreasing the Humoral Response to Factor VIII By Targeted Deletion of Factor VIII - Specific B Cells". Blood 124, n.º 21 (6 de dezembro de 2014): 238. http://dx.doi.org/10.1182/blood.v124.21.238.238.
Texto completo da fonteMazurier, Claudine, Armelle Parquet-Gernez e Maurice Goudemand. "Validation of a Procedure for Potency Assessing of a High Purity Factor VIII Concentrate -Comparison of Different Factor VIII Coagulant Assays and Effect of Prediluent". Thrombosis and Haemostasis 64, n.º 02 (1990): 251–55. http://dx.doi.org/10.1055/s-0038-1647295.
Texto completo da fontePlanque, Stephanie, Miguel A. Escobar, Hiroaki Taguchi, Sangeeta Karle, Yasuhiro Nishiyama, Elizabeth Donnachie e Sudhir Paul. "Irreversible Blockade of Factor VIII Antibodies." Blood 104, n.º 11 (16 de novembro de 2004): 1728. http://dx.doi.org/10.1182/blood.v104.11.1728.1728.
Texto completo da fonteFu, Richard, Meghan J. Lyle, Xuefeng Wang e Carol H. Miao. "Factor VIII-specific CAR regulatory T cells modulate murine anti-factor VIII immune responses". Journal of Immunology 196, n.º 1_Supplement (1 de maio de 2016): 126.13. http://dx.doi.org/10.4049/jimmunol.196.supp.126.13.
Texto completo da fonteHausl, Christina, Rafi U. Ahmad, Maria Sasgary, Christopher B. Doering, Pete S. Lollar, Guenter Richter, Hans Peter Schwarz, Peter L. Turecek e Birgit M. Reipert. "Inhibition of Factor VIII-Specific Memory B Cell Responses by Supra-Physiological Concentrations of Factor VIII." Blood 104, n.º 11 (16 de novembro de 2004): 38. http://dx.doi.org/10.1182/blood.v104.11.38.38.
Texto completo da fonteMertens, Koen, David Gestel, Gunny van Stempvoort, Vincent Limburg, Ed E. Moret e Alexander B. Meijer. "Somatic Mutations in Factor VIII Inhibitors Determine Their Factor VIII Binding and Inhibitory Properties." Blood 110, n.º 11 (16 de novembro de 2007): 1762. http://dx.doi.org/10.1182/blood.v110.11.1762.1762.
Texto completo da fonteTang, Liang, Clark Pan, Harpartap Atwal, Jennifer Nixon, Thomas Barnett, John E. Murphy, Baisong Mei e Michael Fournel. "PEGylation of Factor VIII Reduces the Inhibitory Effects of Human Antibody Inhibitors on the Factor VIII Molecule." Blood 108, n.º 11 (16 de novembro de 2006): 4017. http://dx.doi.org/10.1182/blood.v108.11.4017.4017.
Texto completo da fonteNogami, Keiji, Midori Shima, Tomoko Matsumoto, Katsumi Nishiya, Masahiro Takeyama, Kohei Tatsumi, Ichiro Tanaka e Akira Yoshioka. "Mechanisms of Plasmin-Catalyzed Inactivation of the Factor VIII." Blood 106, n.º 11 (16 de novembro de 2005): 1017. http://dx.doi.org/10.1182/blood.v106.11.1017.1017.
Texto completo da fonte